PBH — Prestige Consumer Healthcare Cashflow Statement
0.000.00%
- $3.99bn
- $4.94bn
- $1.13bn
- 88
- 54
- 91
- 92
Annual cashflow statement for Prestige Consumer Healthcare, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 142 | 165 | 205 | -82.3 | 209 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 23.2 | 27.7 | 23.4 | 394 | 25.7 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 8.8 | -5.6 | -10.9 | -53.9 | -39.8 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 217 | 236 | 260 | 230 | 249 |
Capital Expenditures | -17.3 | -22.2 | -9.64 | -7.78 | -9.55 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.75 | 0 | -247 | -3.8 | -10.6 |
Acquisition of Business | |||||
Sale of Business | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -16.6 | -22.2 | -257 | -11.6 | -20.1 |
Financing Cash Flow Items | -7.56 | -19 | -9.03 | -5.47 | -6.28 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -131 | -279 | -7.57 | -186 | -241 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 67.2 | -62.5 | -5.12 | 31.3 | -12 |